Effect of Oral and Intravenous Insulin and Glutamic Acid Decarboxylase in NOD Mice

References

• Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S. P., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T cell self tolerance to glutamate decarboxylase is a key event in the pathogenesis of murine insulin-dependent diabetes. Nature 1993; 366: 69–71
   PubMed Web of Science ®Google Scholar
• Miller A., Zhang Z. J., Sober R. A., Sabbagh A., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein VS suppression of adoptively transferred disease and differential effects of oral VS intravenous tolerization. J. Neuroimmunol. 1993; 46: 73–82
   PubMed Web of Science ®Google Scholar
• Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein both in vitro and in vivo. Immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. 1992; 89: 421–425
   PubMed Web of Science ®Google Scholar
• Melamed D., Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol 1993; 23: 935–942
   PubMed Web of Science ®Google Scholar
• Whitacre C. C, Gienapp I. E., Orosz C. G., Bitar D. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol 1991; 147: 2155–2163
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Friedman A., Miller A., Khoury S. J., Ai-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol 1994; 12: 809–837
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Mackin G. A., Matsui M., Orav E. J., Khoury S. J., Dawson D. M., Hafler D. A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321–1324
   PubMed Web of Science ®Google Scholar
• Zhang I., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc. Natl Acad. Sci., USA 1991; 88: 10252–10256
   PubMed Web of Science ®Google Scholar
• Gottlieb D. I., Chang Y. C., Schwob J. E. Monoclonal antibodies to glutamic acid decarboxylase. Proc. Natl Acad. Sci. 1986; 83: 8808–8812
   PubMed Web of Science ®Google Scholar
• Atkinson M., Maclaren N., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39(8)933–937
   PubMed Web of Science ®Google Scholar
• Muir A., Peck A., Clare-Salzler M., Song Y-H., Cornelius J., Luchetta R., Krischer J., Maclaren N. K. Insulin immunization of NOD mice induces a protective insulitis characterized by diminished intra-islet interferon-gamma trnscription. J. Clin. Invest. 1995; 95: 628–634
   PubMed Web of Science ®Google Scholar
• Anderson J. T., Cornelius J. G., Jarpe A. J., Winter W. E., Peck A. B. Insulin-dependent diabetes in the NOD mouse model. II. β cell destruction in autoimmune diabetes is a TH2 and not a TH1 event. Autoimmunity 1993; 15: 113–122
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemotherapy Reports 1988; 50: 163–170
   Google Scholar
• Muir A., Schatz D., Maclaren N. Antigen-specific immunotherapy. Oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes. Diab. Metub. Rev. 1993; 9(4)279–287
   PubMed Web of Science ®Google Scholar
• Schott M., Schatz D., Atkinson M., Krischer J., Mehta H., Void B., Maclaren N. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J. Autoimmunity. 1994; 7: 865–872
   PubMed Web of Science ®Google Scholar
• Harrison L. C, Honeyman M. C, Deaizpurua H. J., Schmidli R. S., Colman P. G., Tait B. D., Cram D. S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365–1369
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Maclaren N. K. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 1993; 92: 1608–1616
   PubMed Web of Science ®Google Scholar
• Wegmann D., Gill R., Norbury-Glaser M., Schloot N., Daniel D. Analysis of the spontaneous response to insulin in NOD mice. J. Autoimmunity 1994; 7: 833–843
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Suarez-Pinzon W. L., Sorensen O., Bleackley R. C., Power R. F. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol 1995; 154: 4874–4882
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Sumoski W., Rajotte R. V., Warnock G. L. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 1990; 71: 152–156
   PubMed Web of Science ®Google Scholar
• Foulis A. K., McGill M., Farquharson M. A. Insulin in type I (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J. Pathol 1991; 165: 97–103
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Iscaro A., Harrison L. C. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J. Immunol 1988; 141: 2325–2329
   PubMed Web of Science ®Google Scholar
• Sarvetnick N., Shizuru J., Liggitt D., Martin L., McLntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-gamma. Nature 1990; 346: 844–847
   PubMed Web of Science ®Google Scholar
• Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Immunol, and Immunopath 1994; 71(2)169–175
   PubMedGoogle Scholar
• Campbell I., Kay T. W. H., Oxbrow L., Harrison L. C. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest 1991; 87: 739–742
   PubMed Web of Science ®Google Scholar
• Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185–1188
   PubMed Web of Science ®Google Scholar
• Muir A., Cornelius J., Ramiya V., Peck A. Enhanced TGF-β transcription in draining lymph nodes, but not islets in NOD mice after insulin immunizations that prevent diabetes. Diabetes., (Abstr.) 1995; 44: 298
   Web of Science ®Google Scholar
• Faria A. M., Garcia G., Rios M. J., Michalaros C. L., Vaz N. M. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20–38 week old mice. The effect of intervel between oral exposures and rate of antigen intake in the oral immunization. Immunology 1993; 78: 147–151
   PubMed Web of Science ®Google Scholar